primary immune thrombocytopenia
Conditions
Interventions
test group:On the basis of taking Hetropoxa, add the ginseng astragalus yi qi and blood synthesis (Yueyang Hospital hospital preparation, production batch No.: 2409001) 20 ml at a time, 3 times a day,
control subjects:Administer Hetropofol ethanolamine tablets 2.5 mg once daily.
Sponsors
Yueyang Hospital of Integrative Medicine Shanghai University of Traditional Chinese Medicine China
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Meet diagnostic criteria for primary immune thrombocytopenia; (2) ITP patients who are hormone-resistant or ineffective or who refuse to use hormone therapy; (3) Age =18 years and =70 years gender is not limited; (4) Understand and agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) With severe dysfunction of the heart kidneys liver and lungs; (2) With malignant tumors or other autoimmune diseases; (3) With acute and chronic infectious diseases; (4) Pregnant or lactating women; (5) Participating in other clinical studies within one month prior to the study or currently participating in other clinical studies; (6) Known hypersensitivity to the components of the study drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PLT; | — |
Secondary
| Measure | Time frame |
|---|---|
| Peripheral blood TPO levels;JAK2, STAT3, STAT5, p-JAK2, p-STAT3, p-STAT5 protein expression;The efficacy of qi deficiency symptoms in Chinese medicine;JAK/STAT gene expression level; | — |
Countries
China
Contacts
Public ContactZhu Wenwei
Yueyang Hospital of Integrative Medicine Shanghai University of Traditional Chinese Medicine China
Outcome results
None listed